
CDC Funds Controversial $1.6M Hepatitis B Vaccine Study in Africa
The US plans to fund a controversial $1.6 million study on hepatitis B vaccination in Guinea-Bissau, which critics deem highly unethical due to the withholding of proven effective vaccines and concerns over research integrity and global health implications, amid broader US vaccine policy changes influenced by anti-vaccine activism.













